Fmoc-Lys(Boc)-OH
Names
[ CAS No. ]:
71989-26-9
[ Name ]:
Fmoc-Lys(Boc)-OH
[Synonym ]:
Na-Fmoc-Ne-Boc-L-lysine
N|A-Fmoc-N|A-Boc-L-lysine
EINECS 276-256-4
N-Fmoc-N'-Boc-L-Lysine
Nepsilon-Boc-Nalpha-Fmoc-L-lysine
L-Lysine, N-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-lysine
N-α-FMOC-N-ε-tert-boc-L-lysine
Fmoc-Lys(Boc)
Fmoc-Lys(Boc)-OH
N6-(tert-Butoxycarbonyl)-N2-((9H-fluoren-9-ylmethoxy)carbonyl)-L-lysine
MFCD00037138
(2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-6-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)hexanoic acid
N-alpha-FMOC-Nepsilon-BOC-L-Lysine
N-(tert-Butoxycarbonyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine
N-(9-fluorenyl)methoxycarbonyl-Lys(Boc)-OH
Biological Activity
[Description]:
[Related Catalog]:
[In Vitro]
[References]
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
685.7±55.0 °C at 760 mmHg
[ Melting Point ]:
130-135 °C (dec.)
[ Molecular Formula ]:
C26H32N2O6
[ Molecular Weight ]:
468.542
[ Flash Point ]:
368.5±31.5 °C
[ Exact Mass ]:
468.226044
[ PSA ]:
113.96000
[ LogP ]:
4.97
[ Vapour Pressure ]:
0.0±2.2 mmHg at 25°C
[ Index of Refraction ]:
1.566
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2924299090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2924299090
[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
Nat. Commun. 5 , 5079, (2014)
The remarkable stability of peptide nucleic acids (PNAs) towards enzymatic degradation makes this class of molecules ideal to develop as part of a diagnostic device. Here we report the development of ...
Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab.Eur. J. Pharm. Biopharm. 96 , 217-25, (2015)
Eight-armed PEG was functionalized with furyl and maleimide groups (8armPEG20k-Fur and 8armPEG20k-Mal); degradable hydrogels were obtained by cross-linking via Diels-Alder chemistry. To increase the s...
Chemical synthesis of a polypeptide backbone derived from the primary sequence of the cancer protein NY-ESO-1 enabled by kinetically controlled ligation and pseudoprolines.Biopolymers 104 , 116-27, (2015)
The cancer protein NY-ESO-1 has been shown to be one of the most promising vaccine candidates although little is known about its cellular function. Using a chemical protein strategy, the 180 amino aci...